Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This review discusses partial longitudinal-follicular unit transplantation (PL-FUT) for hair loss and notes its potential to multiply hair follicles while preserving donor areas, but reports no new clinical results.

This article reports on a partial regrowth of scalp hair in a patient treated with extracorporeal photochemotherapy and interferon α 2a, but provides no new clinical outcomes.

This study observed that among hair loss patients in Daejeon and Chungcheong, female pattern hair loss was most common, scalp massage was the preferred management behavior, and satisfaction was above average except for lower satisfaction with folk remedies.

This article highlights that nurses may not be sufficiently aware of the potential for various drug groups, beyond cytotoxic drugs, to cause alopecia, and emphasizes the importance of early recognition of this side effect.

This study demonstrated that switching aE-catenin to aT-catenin in murine skin substantially rescued hyperproliferative and pre-cancerous conditions, but led to partial baldness, indicating potential functional discrepancies.

This article discusses the temporo-parieto-occipital flap for scalp reconstruction and reports no new clinical results; the authors emphasize its specific reconstructive indications.

This study found that dermatological manifestations in COVID-19 patients with severe pneumonia were relatively rare, with the most frequent being the morbilliform viral exanthema and some cases of reversible androgenetic alopecia linked to disease severity.

This review discusses the challenge of linking cutaneous manifestations directly to COVID-19 infection and highlights the inadequate characterization of these skin lesions, reporting no new clinical results.

In this case study, laparoscopic bilateral salpingo-oophorectomy was associated with reduced androgen levels and partial reversal of male-pattern hair loss in a postmenopausal woman with ovarian hyperandrogenism.

Generalized glucocorticoid resistance causes hormone imbalances and varied symptoms due to gene mutations.

This article describes a new surgical technique called "hair-lifting" for treating male-pattern alopecia, which involves removing sections of bald scalp and repositioning remaining hair.

This review evaluates the use of 5α-reductase inhibitors in feminising hormone therapy, finding their additive feminising benefits unclear due to their specific action on testosterone conversion, with concerns highlighted regarding limited supporting evidence and safety signals, particularly for psychiatric and sexual effects.

This study found that daily application of the herbal mixture Xiantene significantly increased hair growth in men with androgenetic alopecia by prolonging the anagen phase, potentially slowing or reversing hair loss.

This study concluded that a 26-year-old woman had autosomal dominantly inherited hereditary cortisol insensitivity, leading to increased adrenocortical cortisol and androgen secretion, which caused clinical symptoms unlike in her male relatives.

This study describes the epidemiologic, clinical, and etiologic characteristics of alopecia among patients at a dermatology service, identifying tinea and alopecia areata as the most common causes.

This article discusses a case of alopecia areata, androgenetic alopecia, and trichostasis spinulosa, highlighting how dermoscopy can help differentiate black dots from trichostasis spinulosa lesions, but it reports no new clinical results.

This case study describes a 34-year-old male developing painful inflammatory scalp nodules post-scalp microinfusion of medication. The findings suggest that repeated microtrauma or bacterial colonization might trigger dissecting cellulitis in susceptible individuals, with exogenous testosterone as a potential modifier, not a direct cause.

This case report details the ocular complications of Hutchinson-Gilford Progeria syndrome in a 20-year-old Bangladeshi patient, highlighting symptoms like dry eyes, Meibomian gland dysfunction, and cataracts.

This discussion highlights the evolving clinical spectrum of lichen planopilaris, noting atypical features and presentations in younger males that suggest potential different pathomechanisms from previously recognized variants.

A man's skin cancer improved and some of his hair grew back after treatment with a special light therapy and a medication.

This case study reported two instances of female androgenetic alopecia with male pattern reversed after surgical removal of an ovarian tumor.

This pilot study found that a single session of nanofat treatment may increase hair thickness and density in male patients with androgenic alopecia, with effects lasting up to 12 months in some cases, though results varied.

Tigason improved hair growth in a boy with monilethrix without side effects.

This review examines the therapeutic applications and potential pharmacological properties of Calotropis gigantea but presents no new clinical findings.

This study identified distinct differences in metabolic pathways related to pattern baldness, with findings highlighting the androgen metabolic pathway in males and the estrogen plus arachidonic acid pathways in females using hair samples.

This study concluded that there is no association between male pattern baldness and the severity or presence of coronary artery disease as measured by Gensini and Rentrop scores.

This article introduces a new theory on male pattern baldness, attributing it to scalp pressure affecting hair follicles, and suggests it could revolutionize understanding and treatment; no clinical results are presented.

This review found that commercial influences may affect how male baldness is represented as a disease and how treatment options are presented, often omitting limitations.

A new, less toxic and more efficient method to create the anti-baldness compound RU58841 was developed in 2014.

This case report suggests that a classical homeopathic approach at Dr Batra’s® Homeopathy Clinic significantly improved hair fall, hair density, and quality of life for a young male with Grade III Male Pattern Baldness over 18 months.